Learn More
Medchemexpress LLC Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA | 2435572-49-7 | 99.28% | 648.58 | 50 MG

Supplier: Medchemexpress LLC HY112600A50MG
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology. At equivalent molar concentrations, both the salt and free forms of a compound exhibit comparable biological activity. Nevertheless, the salt form usually boasts enhanced water solubility and stability.
- Synthesized E3 ligase ligand-linker conjugate
- Incorporates thalidomide based cereblon ligand
- Features a 3-unit PEG linker for PROTAC technology
- Salt form offers enhanced water solubility and stability
- For research use only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.